Jeffrey Chow is a Nephrology physician. OpenAlex indexes 6 publications with 201 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10605 Balboa Blvd Ste 240
Granada Hills, CA 913446374
Telephone
818-366-4626Provider last certified this registry record 1 Feb 2024.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202412 payments
- AstraZeneca Pharmaceuticals LPProgram year20246 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.1%Calcium channel blocker10.8%Amlodipine Besylate85%Nifedipine Er15%Part D<11 patientsLoop diuretic10.4%Furosemide100%Part D≥40 patients+ 10 more classes in this area
Metabolism & gastrointestinal
15.2%SGLT2 inhibitor9.3%Jardiance71%Farxiga29%Part D<11 patientsVitamin D3 Analog3.5%Calcitriol100%Part D≥11 patients+ 1 more class in this area
Genitourinary & hormones
4.7%alpha-Adrenergic Blocker4.7%Tamsulosin Hcl100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cardiovascular risk factor modification among high-risk patients
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
2013 - MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1
Clinical & Experimental Metastasis
2005 - Molecular Aspects of Ultraviolet Radiation-induced Apoptosis in the Skin
Journal of Cutaneous Medicine and Surgery
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”